Cargando…

Performance Evaluation of RapiSure (EDGC) COVID-19 S1 RBD IgG/Neutralizing Ab Test for the Rapid Detection of SARS-CoV-2 Antibodies

The accurate detection of anti-neutralizing SARS-CoV-2 antibodies can aid in the understanding of the development of protective immunity against COVID-19. This study evaluated the diagnostic performance of the RapiSure (EDGC) COVID-19 S1 RBD IgG/Neutralizing Ab Test. Using the 90% plaque reduction n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Ha Nui, Yoon, Jung, Jang, Woong Sik, Lim, Chae Seung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9955181/ https://www.ncbi.nlm.nih.gov/pubmed/36832131 http://dx.doi.org/10.3390/diagnostics13040643

Ejemplares similares

Feasibility of the Use of RapiGraft and Skin Grafting in Reconstructive Surgery
por: Yang, Jung Dug, et al.
Publicado: (2016)

Seroconversion and Abundance of IgG Antibodies against S1-RBD of SARS-CoV-2 and Neutralizing Activity in the Chilean Population
por: González-Stegmaier, R., et al.
Publicado: (2021)

Comparative evaluation of three dengue duo rapid test kits to detect NS1, IgM, and IgG associated with acute dengue in children in Myanmar
por: Jang, Woong Sik, et al.
Publicado: (2019)

Correlation between Commercial Anti-RBD IgG Titer and Neutralization Titer against SARS-CoV-2 Beta Variant
por: Poon, Rosana Wing-Shan, et al.
Publicado: (2021)

Performance evaluation of three rapid antigen tests for the diagnosis of group A Streptococci
por: Kim, Ha-Nui, et al.
Publicado: (2019)

Rapid Detection of Mycobacterium Tuberculosis Using a Novel Point-of-Care BZ TB/NTM NALF Assay: Integrating LAMP and LFIA Technologies
por: Kim, Ha Nui, et al.
Publicado: (2023)

Novel human neutralizing mAbs specific for Spike-RBD of SARS-CoV-2
por: Passariello, Margherita, et al.
Publicado: (2021)

Multiepitope Proteins for the Differential Detection of IgG Antibodies against RBD of the Spike Protein and Non-RBD Regions of SARS-CoV-2
por: Gomes, Larissa R., et al.
Publicado: (2021)

Evolution of Anti-RBD IgG Avidity following SARS-CoV-2 Infection
por: Tauzin, Alexandra, et al.
Publicado: (2022)

Anti-RBD IgG antibodies and neutralizing antibody levels after the second BNT162b2 dose in patients with plasma cell disorders
por: Magen, Hila, et al.
Publicado: (2023)

Landscape of the RBD-specific IgG, IgM, and IgA responses triggered by the inactivated virus vaccine against the Omicron variant
por: Xue, Jun-biao, et al.
Publicado: (2022)

RBD and Spike DNA-Based Immunization in Rabbits Elicited IgG Avidity Maturation and High Neutralizing Antibody Responses against SARS-CoV-2
por: da Costa, Hernan H. M., et al.
Publicado: (2023)

Detection of Anti-SARS-CoV-2-S2 IgG Is More Sensitive Than Anti-RBD IgG in Identifying Asymptomatic COVID-19 Patients
por: Liao, Baolin, et al.
Publicado: (2021)

Immunoglobulin fragment F(ab’)(2) against RBD potently neutralizes SARS-CoV-2 in vitro
por: Pan, Xiaoyan, et al.
Publicado: (2020)

BNT162b2 Third Booster Dose Significantly Increases the Humoral Response Assessed by Both RBD IgG and Neutralizing Antibodies in Renal Transplant Recipients
por: Hod, Tammy, et al.
Publicado: (2022)

Correlation Analysis of Anti-SARS-CoV-2 RBD IgG and Neutralizing Antibody against SARS-CoV-2 Omicron Variants after Vaccination
por: Takheaw, Nuchjira, et al.
Publicado: (2022)

Specific Antibody Deficiency in Adult Patients With IgG or IgG Subclass Deficiency
por: Kim, Joo-Hee, et al.
Publicado: (2020)

Anti-RBD IgA and IgG Response and Transmission in Breast Milk of Anti-SARS-CoV-2 Vaccinated Mothers
por: Trofin, Felicia, et al.
Publicado: (2022)

Disparity between levels of anti-RBD IgG and anti-nucleocapsid protein IgG antibodies in COVID-19–recovered patients who received a kidney transplant
por: Chang, Chih-Chao, et al.
Publicado: (2021)

Transport of neutral IgG2 versus anionic IgG4 in PD: implications on the electrokinetic model
por: Pletinck, Anneleen, et al.
Publicado: (2018)

Development and evaluation of a low cost IgG ELISA test based in RBD protein for COVID-19
por: Villafañe, Luciana, et al.
Publicado: (2022)

Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes
por: Voss, William N., et al.
Publicado: (2021)

Prevalence of HAV Ab, HEV (IgG), HSV2 IgG, and Syphilis Among Sheltered Homeless Adults in Tehran, 2012
por: Jahanbakhsh, Fatemeh, et al.
Publicado: (2017)

L-RAPiT: A Cloud-Based Computing Pipeline for the Analysis of Long-Read RNA Sequencing Data
por: Nelson, Theodore M., et al.
Publicado: (2022)

Development of in-house ELISAs for the detection of anti-SARS‑CoV‑2 RBD and N IgG and IgM antibodies in biological samples
por: Ibrahim, Essam H., et al.
Publicado: (2021)

Direct IgG epitope mapping on bacterial AB toxins by cryo-EM
por: Nguyen, Tri, et al.
Publicado: (2021)

Testing IgG antibodies against the RBD of SARS-CoV-2 is sufficient and necessary for COVID-19 diagnosis
por: Indenbaum, Victoria, et al.
Publicado: (2020)

Avidity of IgG to SARS-CoV-2 RBD as a Prognostic Factor for the Severity of COVID-19 Reinfection
por: Manuylov, Victor, et al.
Publicado: (2022)

Natural IgG against S-Protein and RBD of SARS-CoV-2 Do Not Bind and Hydrolyze DNA and Are Not Autoimmune
por: Timofeeva, Anna M., et al.
Publicado: (2022)

Design and optimization of an IgG human ELISA assay reactive to recombinant RBD SARS-CoV-2 protein
por: Rodríguez, María Celeste, et al.
Publicado: (2022)

A computational method for predicting the aggregation propensity of IgG1 and IgG4(P) mAbs in common storage buffers
por: Heads, James T., et al.
Publicado: (2022)

Long-term decay of anti-RBD IgG titers after BNT162b2 vaccination is not mirrored by loss of neutralizing bioactivity against SARS-CoV-2
por: Malipiero, Giacomo, et al.
Publicado: (2022)

RapiData: a practical course in macromolecular X-ray diffraction data measurement and structure solving at the NSLS
por: Sweet, R. M., et al.
Publicado: (2010)

Anti-spike S1 IgA, anti-spike trimeric IgG, and anti-spike RBD IgG response after BNT162b2 COVID-19 mRNA vaccination in healthcare workers
por: Salvagno, Gian Luca, et al.
Publicado: (2021)

Natural IgG Anti-F (ab’)(2) Autoantibody Activity in Children with Autism
por: Tordjman, Sylvie, et al.
Publicado: (2023)

Mechanism of neutralization of influenza virus by secretory IgA is different from that of monomeric IgA or IgG
Publicado: (1985)

SARS-CoV-2 spike RBD-specific IgA and IgG antibodies in breast milk after vaccination with the protein subunit vaccine Abdala
por: Pérez-Bernal, Maylin, et al.
Publicado: (2022)

Subclasses of allergen-specific IgG: Serum IgG2 and IgG3 levels are not predicted by IgG1/IgG4 levels
por: MacGlashan, Donald, et al.
Publicado: (2021)

An Audit and Feedback Intervention for Reducing Antibiotic Prescribing in General Dental Practice: The RAPiD Cluster Randomised Controlled Trial
por: Elouafkaoui, Paula, et al.
Publicado: (2016)

Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies
por: Takahashi, Maika, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8ja5l7d15sl8dju1t5lphiun2g